Viewing Study NCT01927757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:58 PM
Ignite Modification Date: 2026-03-13 @ 1:28 PM
Study NCT ID: NCT01927757
Status: TERMINATED
Last Update Posted: 2018-01-30
First Post: 2013-06-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate to Severe Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rheumatoid arthritis View
None etanercept View
None arthritis View
None adalimumab failure to respond View
None loss of response to adalimumab View
None ACR20 View
None methotrexate View
None Swollen joints View
None tender joints View